This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: The General Hospital Corporation, University of California. Active years: 2022.
Company Filing History:
1 out of 3,070 
1 out of 15,988 
Years Active: 2022
Title: Matt Brenner: Innovator in Cyanide Poisoning Antidotes
Introduction
Matt Brenner is a notable inventor based in Irvine, California. He has made significant contributions to the field of medicine, particularly in developing antidotes for cyanide poisoning. His innovative work has the potential to save lives in critical situations.
Latest Patents
Matt Brenner holds a patent for a compound designed to treat and prevent cyanide poisoning. The patent details a compound of Formula (I) or a pharmaceutically acceptable salt thereof, along with methods for its use. This invention is crucial for addressing the dangers associated with cyanide exposure.
Career Highlights
Throughout his career, Matt Brenner has worked with reputable organizations, including The General Hospital Corporation and the University of California. His experience in these institutions has allowed him to advance his research and contribute to significant medical advancements.
Collaborations
Matt has collaborated with esteemed colleagues such as Randall T. Peterson and Robert Gerszten. These partnerships have fostered a productive environment for innovation and research in the medical field.
Conclusion
Matt Brenner's work in developing antidotes for cyanide poisoning exemplifies his commitment to innovation in medicine. His contributions are vital for enhancing public health and safety.